1 drug(s) with this reaction
385 total reports
Dizziness has been reported as an adverse reaction across 1 drug(s) manufactured by Ipsen Biopharmaceuticals Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 385 adverse event reports mention dizziness in connection with Ipsen Biopharmaceuticals Inc products.
This page provides a breakdown of which Ipsen Biopharmaceuticals Inc drugs are most commonly associated with dizziness, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Ipsen Biopharmaceuticals Inc drugs have dizziness listed in their FDA adverse event reports, sorted by report count:
In addition to dizziness, the following adverse reactions have been reported across Ipsen Biopharmaceuticals Inc's drug portfolio:
1 drug(s) manufactured by Ipsen Biopharmaceuticals Inc have dizziness listed in their FDA adverse event reports: LANREOTIDE ACETATE.
There are a combined 385 reports of dizziness across 1 Ipsen Biopharmaceuticals Inc drug(s) in the FDA adverse event database.